Chlorine in PDB 2ag2: Crystal Structure Analysis of GM2-Activator Protein Complexed with Phosphatidylcholine
Protein crystallography data
The structure of Crystal Structure Analysis of GM2-Activator Protein Complexed with Phosphatidylcholine, PDB code: 2ag2
was solved by
C.S.Wright,
L.Z.Mi,
S.Lee,
F.Rastinejad,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
19.76 /
2.00
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
63.530,
86.190,
120.480,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
18.8 /
23.1
|
Chlorine Binding Sites:
The binding sites of Chlorine atom in the Crystal Structure Analysis of GM2-Activator Protein Complexed with Phosphatidylcholine
(pdb code 2ag2). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total 3 binding sites of Chlorine where determined in the
Crystal Structure Analysis of GM2-Activator Protein Complexed with Phosphatidylcholine, PDB code: 2ag2:
Jump to Chlorine binding site number:
1;
2;
3;
Chlorine binding site 1 out
of 3 in 2ag2
Go back to
Chlorine Binding Sites List in 2ag2
Chlorine binding site 1 out
of 3 in the Crystal Structure Analysis of GM2-Activator Protein Complexed with Phosphatidylcholine
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 1 of Crystal Structure Analysis of GM2-Activator Protein Complexed with Phosphatidylcholine within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl801
b:16.1
occ:1.00
|
O
|
C:HOH3701
|
3.0
|
33.4
|
1.0
|
CB
|
A:CYS83
|
3.2
|
18.8
|
1.0
|
N
|
A:LEU51
|
3.2
|
15.1
|
1.0
|
N
|
A:CYS83
|
3.3
|
13.2
|
1.0
|
CA
|
A:HIS81
|
3.4
|
13.3
|
1.0
|
C
|
A:HIS81
|
3.5
|
14.4
|
1.0
|
CB
|
A:HIS81
|
3.5
|
14.7
|
1.0
|
CB
|
A:SER49
|
3.5
|
20.4
|
1.0
|
SG
|
A:CYS83
|
3.6
|
22.2
|
1.0
|
CA
|
A:PRO50
|
3.7
|
18.6
|
1.0
|
CA
|
A:CYS83
|
3.7
|
17.6
|
1.0
|
N
|
A:PHE82
|
3.8
|
16.6
|
1.0
|
CA
|
A:SER49
|
3.8
|
19.2
|
1.0
|
N
|
A:ASP84
|
3.9
|
14.2
|
1.0
|
C
|
A:PRO50
|
3.9
|
17.9
|
1.0
|
O
|
A:HIS81
|
3.9
|
12.8
|
1.0
|
CD2
|
A:HIS81
|
4.1
|
16.7
|
1.0
|
O
|
A:LEU51
|
4.1
|
16.9
|
1.0
|
CG
|
A:HIS81
|
4.1
|
14.7
|
1.0
|
CA
|
A:LEU51
|
4.2
|
15.8
|
1.0
|
CB
|
A:LEU51
|
4.3
|
17.9
|
1.0
|
C
|
A:PHE82
|
4.3
|
15.1
|
1.0
|
C
|
A:CYS83
|
4.3
|
17.3
|
1.0
|
C
|
A:LEU51
|
4.6
|
15.8
|
1.0
|
CB
|
A:PRO50
|
4.6
|
19.6
|
1.0
|
CA
|
A:PHE82
|
4.6
|
15.2
|
1.0
|
N
|
A:PRO50
|
4.6
|
18.8
|
1.0
|
N
|
A:SER49
|
4.7
|
18.1
|
1.0
|
C
|
A:SER49
|
4.8
|
18.0
|
1.0
|
N
|
A:HIS81
|
4.8
|
13.4
|
1.0
|
O
|
C:HOH3703
|
4.8
|
38.3
|
1.0
|
OG
|
A:SER49
|
4.9
|
29.4
|
1.0
|
O
|
A:GLU80
|
5.0
|
15.2
|
1.0
|
CB
|
A:ASP84
|
5.0
|
18.8
|
1.0
|
|
Chlorine binding site 2 out
of 3 in 2ag2
Go back to
Chlorine Binding Sites List in 2ag2
Chlorine binding site 2 out
of 3 in the Crystal Structure Analysis of GM2-Activator Protein Complexed with Phosphatidylcholine
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 2 of Crystal Structure Analysis of GM2-Activator Protein Complexed with Phosphatidylcholine within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl802
b:19.3
occ:1.00
|
O
|
A:HOH2495
|
2.8
|
29.8
|
1.0
|
N
|
B:LEU51
|
3.2
|
17.7
|
1.0
|
CB
|
B:CYS83
|
3.3
|
18.6
|
1.0
|
N
|
B:CYS83
|
3.3
|
12.7
|
1.0
|
CA
|
B:HIS81
|
3.4
|
14.9
|
1.0
|
C
|
B:HIS81
|
3.5
|
12.9
|
1.0
|
SG
|
B:CYS83
|
3.6
|
23.2
|
1.0
|
CB
|
B:HIS81
|
3.6
|
14.5
|
1.0
|
CA
|
B:PRO50
|
3.6
|
21.2
|
1.0
|
CB
|
B:SER49
|
3.7
|
25.8
|
1.0
|
N
|
B:PHE82
|
3.8
|
16.8
|
1.0
|
CA
|
B:CYS83
|
3.8
|
14.7
|
1.0
|
CA
|
B:SER49
|
3.8
|
23.7
|
1.0
|
C
|
B:PRO50
|
3.9
|
21.9
|
1.0
|
ND1
|
B:HIS81
|
3.9
|
16.4
|
1.0
|
O
|
B:HIS81
|
3.9
|
13.6
|
1.0
|
N
|
B:ASP84
|
4.0
|
13.8
|
1.0
|
O
|
B:LEU51
|
4.0
|
17.0
|
1.0
|
CA
|
B:LEU51
|
4.2
|
18.7
|
1.0
|
CG
|
B:HIS81
|
4.2
|
13.3
|
1.0
|
CB
|
B:LEU51
|
4.3
|
17.6
|
1.0
|
C
|
B:PHE82
|
4.4
|
14.0
|
1.0
|
C
|
B:CYS83
|
4.4
|
15.3
|
1.0
|
C
|
B:LEU51
|
4.5
|
18.1
|
1.0
|
CB
|
B:PRO50
|
4.5
|
18.5
|
1.0
|
CA
|
B:PHE82
|
4.7
|
13.1
|
1.0
|
N
|
B:PRO50
|
4.7
|
22.4
|
1.0
|
N
|
B:HIS81
|
4.7
|
13.8
|
1.0
|
N
|
B:SER49
|
4.7
|
19.8
|
1.0
|
O
|
B:GLU80
|
4.8
|
16.0
|
1.0
|
C
|
B:SER49
|
4.8
|
23.9
|
1.0
|
O
|
A:HOH2544
|
4.9
|
39.6
|
1.0
|
O
|
A:HOH2472
|
4.9
|
42.3
|
1.0
|
|
Chlorine binding site 3 out
of 3 in 2ag2
Go back to
Chlorine Binding Sites List in 2ag2
Chlorine binding site 3 out
of 3 in the Crystal Structure Analysis of GM2-Activator Protein Complexed with Phosphatidylcholine
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 3 of Crystal Structure Analysis of GM2-Activator Protein Complexed with Phosphatidylcholine within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Cl803
b:23.9
occ:1.00
|
O
|
C:HOH3724
|
3.2
|
33.1
|
1.0
|
N
|
C:CYS83
|
3.3
|
17.2
|
1.0
|
CB
|
C:CYS83
|
3.3
|
21.4
|
1.0
|
N
|
C:LEU51
|
3.3
|
18.5
|
1.0
|
CA
|
C:HIS81
|
3.5
|
17.5
|
1.0
|
C
|
C:HIS81
|
3.6
|
17.8
|
1.0
|
SG
|
C:CYS83
|
3.6
|
24.9
|
1.0
|
CB
|
C:SER49
|
3.6
|
28.6
|
1.0
|
N
|
C:PHE82
|
3.7
|
17.5
|
1.0
|
CA
|
C:PRO50
|
3.7
|
21.1
|
1.0
|
CA
|
C:CYS83
|
3.8
|
21.5
|
1.0
|
CA
|
C:SER49
|
3.8
|
28.0
|
1.0
|
C
|
C:PRO50
|
4.0
|
19.6
|
1.0
|
N
|
C:ASP84
|
4.1
|
18.3
|
1.0
|
O
|
C:HIS81
|
4.1
|
14.1
|
1.0
|
CB
|
C:HIS81
|
4.2
|
18.3
|
1.0
|
O
|
C:LEU51
|
4.2
|
21.5
|
1.0
|
CA
|
C:LEU51
|
4.3
|
20.5
|
1.0
|
C
|
C:PHE82
|
4.4
|
18.8
|
1.0
|
CB
|
C:LEU51
|
4.4
|
23.8
|
1.0
|
C
|
C:CYS83
|
4.5
|
20.6
|
1.0
|
O
|
C:GLU80
|
4.5
|
20.1
|
1.0
|
CA
|
C:PHE82
|
4.6
|
20.5
|
1.0
|
CB
|
C:PRO50
|
4.6
|
22.1
|
1.0
|
C
|
C:LEU51
|
4.7
|
19.6
|
1.0
|
OD1
|
C:ASP84
|
4.7
|
21.4
|
1.0
|
N
|
C:PRO50
|
4.7
|
24.4
|
1.0
|
N
|
C:HIS81
|
4.8
|
12.1
|
1.0
|
N
|
C:SER49
|
4.8
|
20.7
|
1.0
|
C
|
C:SER49
|
4.8
|
24.1
|
1.0
|
CG
|
C:ASP84
|
4.9
|
26.3
|
1.0
|
ND1
|
C:HIS81
|
4.9
|
26.1
|
1.0
|
OG
|
C:SER49
|
5.0
|
36.1
|
1.0
|
|
Reference:
C.S.Wright,
L.Z.Mi,
S.Lee,
F.Rastinejad.
Crystal Structure Analysis of Phosphatidylcholine-GM2-Activator Product Complexes: Evidence For Hydrolase Activity. Biochemistry V. 44 13510 2005.
ISSN: ISSN 0006-2960
PubMed: 16216074
DOI: 10.1021/BI050668W
Page generated: Sat Jul 20 05:13:18 2024
|